16
NPS Score
VS
bluebird bio
- EMPLOYEE
PARTICIPANTS - 7
- TOTAL
RATINGS
Spark Therapeutics
- EMPLOYEE
PARTICIPANTS - 14
- TOTAL
RATINGS
bluebird bio vs Spark Therapeutics
Compare bluebird bio versus Spark Therapeutics for CEO Rating, Overall Culture Score, Brand Ranking, and other ratings. Results were generated by 7 employees and customers of bluebird bio and 14 employees and customers of Spark Therapeutics.
bluebird bio
bluebird bio's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of bluebird bio. Their current market cap is $410.75M.
Spark Therapeutics
Spark Therapeutics's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of Spark Therapeutics. Their current market cap is $4.29B.
4.2/5
Product Quality
3.7/5
4/5
Pricing
5/5
3.9/5
Customer Service
5/5
| 33% | Promoters |
|---|---|
| 50% | Passive |
| 17% | Detractors |
100
NPS Score
| 100% | Promoters |
|---|---|
| 0% | Passive |
| 0% | Detractors |
Net Promoter Score
Winner by 84
See how bluebird bio compares to its competitors
Working at bluebird bio vs Working at Spark Therapeutics
49 / 100
CEO Rating
68 / 100
CEO Rating
Winner by 19%
bluebird bio
bluebird bio doesn't have enough ratings to calculate the Team Culture Ratings.
Know someone that works there? Invite them to rate their experience.
Spark Therapeutics
Employees at Spark Therapeutics rate their CEO, Jeffrey Marrazzo, 68/100. This score is 19% higher than the scores of bluebird bio's CEO, Nick Leschly.